Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05839847 · ClinicalTrials.gov registry record · NA

LIFU for Anxiety Management

A NA study of Anxiety, sponsored by Virginia Polytechnic Institute and State University.

Active
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT05839847: Active NA study of Anxiety, sponsored by Virginia Polytechnic Institute and State University.

NCT05839847 is a NA study of Anxiety that is active but no longer recruiting, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 44 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05839847, a NA study of Anxiety, is active but no longer recruiting, sponsored by Virginia Polytechnic Institute and State University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

This study is examining the effects of noninvasive brain stimulation on anxiety. Low-intensity focused ultrasound (LIFU) will be utilized to neuromodulate the brain prior to a task (NPU). Physiological recordings will be taken throughout (EEG, EMG, HR, BP, RR, GSR).

Primary Outcome

Attenuated amplitude of startle reflex during uncertain and predictable threat tasks with lifu compared to sham.

Conditions Studied

Interventions

  • DEVICE Low-intensity focused ultrasound
  • DEVICE Low-intensity focused ultrasound - sham

Study Locations (1)

Virginia

  • Fralin Biomedical Research Institute at VTC - Roanoke

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2023-12-20
Est. Completion 2026-04-01
Phase NA

What the registry record for NCT05839847 still lists

NCT05839847 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Low-intensity focused ultrasound is the first listed.

NCT05839847 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT05839847 about?

NCT05839847 is a clinical study titled "LIFU for Anxiety Management". This study is examining the effects of noninvasive brain stimulation on anxiety. Low-intensity focused ultrasound (LIFU) will be utilized to neuromodulate the brain prior to a task (NPU). Physiological recordings will be taken throughout (EEG, EMG, HR, BP, RR, GSR).

What is the current status of trial NCT05839847?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2023-12-20. Estimated completion is 2026-04-01.

What conditions does trial NCT05839847 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT05839847?

The interventions under investigation include: Low-intensity focused ultrasound (DEVICE), Low-intensity focused ultrasound - sham (DEVICE).

Who is sponsoring clinical trial NCT05839847?

This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05839847 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05839847's enrollment target sits among peer trials

44 261st of 364 higher than 102 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05839847, the US trial registry maintained by the National Library of Medicine. NCT05839847 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.